Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for the supply of Tocilizumab Injection - 01 March 2026
Offer reference number: CM/TNS/25/5723
Period of framework: 1 March 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Celltrion Healthcare United Kingdom Limited | 11685363 | £150,085,000 | 1 lot Lot 1 | - |
| Fresenius Kabi Limited | 02182135 | £150,085,000 | 1 lot Lot 1 | - |
| Roche Products Ltd | 00100674 | £150,085,000 | 1 lot Lot 1 | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
This procurement was divided into 1 lots, each awarded separately. 3 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Mar 2026 – Aug 2027 | £188,195,000 £150,085,000 initial term | 3 | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| Celltrion Healthcare United Kingdom Limited | Lot 1 | Won |
| Fresenius Kabi Limited | Lot 1 | Won |
| Roche Products Ltd | Lot 1 | Won |
Weightings from the notice.
Government spending data: These suppliers have received £218,201,939 in 4,773 payments (over £25k) from NHS Supply Chain (DHSC-funded), Department of Health and Social Care, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Guy's and St Thomas' NHS FT and 13 more public bodies (2019-10-17 to 2026-03-31).